Aspects of the Design and Delivery of Microparticles for Vaccine Applications
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 3 (1) , 79-81
- https://doi.org/10.3109/10611869509015939
Abstract
Mortality and morbidity data continue to indicate there is a compelling need for the derivation of a new generation of vaccine delivery systems that can be usefully applied via injection and also mucosally. One technology that has potential for design as an effective vaccine delivery system is the formulation of biodegradable microparticles from the polymers and poly lactide co-glycolide (PLGA) in particular. The potential advantages of the delivery of vaccines within such microparticles is discussed. The potential for eliciting and optimising immunity after the mucosal delivery of biodegradable microparticles is also discussed.Keywords
This publication has 8 references indexed in Scilit:
- Microparticulate absorption from the rat intestineJournal of Controlled Release, 1994
- The quantitation of the absorption of microparticles into the intestinal lymph of Wistar ratsInternational Journal of Pharmaceutics, 1994
- The Children's Vaccine Initiative--Will It Work?The Journal of Infectious Diseases, 1993
- Controlled-Release Vaccines-Biodegradable Polylactide/Polyglycolide (PL/PG) Microspheres as Antigen VehiclesImmunobiology, 1992
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992
- Oral Delivery of VaccinesClinical Pharmacokinetics, 1992
- Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size DependencyJournal of Pharmacy and Pharmacology, 1990
- A Method for Quantifying Particle Absorption from the Small Intestine of the MousePharmaceutical Research, 1990